Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
Regardless of the promising results of certain immune checkpoint blockers, current immunotherapeutics have met a bottleneck concerning response rate, toxicity, and resistance in lung cancer patients. Accumulating evidence forecasts that the crosstalk between tumor and immune cells takes center stage...
Main Authors: | Poonam Sarode, Martina Barbara Schaefer, Friedrich Grimminger, Werner Seeger, Rajkumar Savai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00324/full |
Similar Items
-
Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
by: Annika Karger, et al.
Published: (2021-08-01) -
Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
by: Prameela Kandra, et al.
Published: (2022-06-01) -
Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity
by: Siavash Mansouri, et al.
Published: (2022-09-01) -
Identification of tumor‐associated macrophage subsets that are associated with breast cancer prognosis
by: Elisabeth Strack, et al.
Published: (2020-12-01) -
The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC
by: Sebastian Marwitz, et al.
Published: (2020-01-01)